SYDNEY--Personal-protective equipment maker Ansell beat analysts' dividend forecasts after price rises and sourcing changes offset U.S. tariff impacts and helped drive a stronger-than-expected annual profit.

The Australia-listed company, which reports in U.S. dollars, on Monday reported a net profit for the 12 months through June of $208.6 million, up from $101.6 million a year earlier.

Revenue rose by 6.8% to $2.14 billion, or by 5.0% in constant-currency terms. Growth accelerated in the June half, supported by improved volumes.

The average analyst forecast had been for a net profit of $191.9 million from revenue of $2.07 billion, according to data compiled by Visible Alpha.

Ansell, which manufactures the majority of its products in Malaysia, Sri Lanka, Thailand, Vietnam and China, said it offset the impact of the Trump administration's tariffs and inflation linked to the Middle East conflict by raising prices and managing its sourcing.

The company had previously said that it would redirect supply to the U.S. from countries with a lower tariff burden.

Earnings per share rose by 18% to $1.486, on an adjusted basis. The board declared a dividend of 41.5 cents, up from 28.0 cents.

Ansell had guided for EPS of between $1.37 and $1.49, on an adjusted basis, which represented 13% growth at the range midpoint. Analysts had been looking for almost $1.44, according to Visible Alpha data.

Ansell said that it expected adjusted EPS of between $1.58 and $1.70 for the 12 months that began July 1. That compared with current consensus for almost A$1.52.

"My focus as we move forward will be to accelerate profitable growth and improve our customer centricity," said Chief Executive Nathalie Ahlstrom, who replaced Neil Salmon at the helm following February's half-year result announcement.

For the year ended June 30, Ansell said sales from its industrial unit, which supplies businesses including manufacturers, miners and construction firms, rose 3.3% on an organic, constant-currency basis to $947.3 million. Unit earnings lifted 7.9%.

On the same basis, healthcare sales rose by 6.4% to $1.19 billion and earnings increased by 6.7%.

Ahlstrom said Ansell would prioritize strategic markets with the most profitable growth potential, while continuing to simplify the company's product and brand portfolios.

The U.S. would be one of those markets, Ansell said. The company added that it anticipates constant-currency sales growth from both higher volumes and the price rises implemented in the past year.